2020-08-14T13:05:46-05:00 2019-09-30 ERNST & YOUNG US LLP 18101 VON KARMAN AVE SUITE 1700 IRVINE CA 92612 990 2018-10-01 953435919 CITY OF HOPE % JENNIFER PARKHURST CITY 6262564673 1500 EAST DUARTE ROAD DUARTE CA 91010 JENNIFER PARKHURST CFO 2020-08-05 true Kara Adams P00023315 9497942300 76.103.183.71 33577420202275000027 2020-08-14 P D557AE15DEE7CB4B05DACC65102BA7DE9D2F1E46 C14809353AC8B922CDA71DEA69DCA1FF1BA1B89C 2018 2020-09-23 17:36:50Z ROBERT W STONE 1500 EAST DUARTE ROAD DUARTE CA 91010 1558555763 false X WWW.CITYOFHOPE.ORG X 1980 CA TO RAISE FUNDS TO SUPPORT AND TRANSFORM THE FUTURE OF HEALTH CARE BY TURNING SCIENCE INTO PRACTICAL BENEFIT AND HOPE FOR CURES INTO REALITY. 12 12 194 10000 1803553 0 141961318 113932956 0 0 60386081 95891113 443266174 382657996 645613573 592482065 470090717 424657006 0 0 31310578 34717658 5416023 5430865 27584670 23467742 23718219 530285060 488523748 115328513 103958317 1610966444 1796402120 63189019 80963867 1547777425 1715438253 X CITY OF HOPE PROVIDES FINANCIAL SUPPORT FOR ADVANCEMENT OF TREATMENTS TO PERSONS SUFFERING FROM CANCER, DIABETES, AND OTHER LIFE-THREATENING DISEASES. CONTINUED ON SCHEDULE O false false 424657006 424657006 0 GRANTS TO SUPPORT MEDICAL RESEARCH AND HEALTH CARE DELIVERY OF SERVICES FOR CITY OF HOPE NATIONAL MEDICAL CENTER, CITY OF HOPE MEDICAL FOUNDATION, ACCESS CITY OF HOPE, LLC, AND BIOMEDICAL RESEARCH CONDUCTED AT THE BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE AND THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE. 1676627 0 0 A VARIETY OF SOCIAL SERVICES INCLUDING COMMUNITY OUTREACH, ADVOCACY AND HEALTH EDUCATION; HEALTH, PREVENTION, TREATMENT AND SURVIVORSHIP INFORMATION FOR PATIENTS AND FAMILIES; AND VARIOUS MEDICAL EDUCATION ACTIVITIES INCLUDING CANCER, DIABETES AND HIV/AIDS AWARENESS AND PREVENTION THAT ARE CONDUCTED AT THE MEDICAL CENTER, THE BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE, AND CITY OF HOPE MEDICAL FOUNDATION. 426333633 true true false false false false false false false true true true false false true true false true false false true false false true true false false true false true false false false false false false false false true false false false true true true true false false true X 163 4 true 194 true true true true BD CJ false false false true true false false false false true false X 12 12 true false false false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DE FL GA HI IL IN KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT WA WV WI X JENNIFER PARKHURST 6262564673 1500 EAST DUARTE ROAD DUARTE CA 91010 ANTHONY SCOTT BOARD MEMBER (PT YR) 2.0 0.0 X 0 0 0 BARBARA BRUSER BOARD MEMBER 2.0 0.0 X 0 0 0 GLENN STEELE MD PHD BOARD MEMBER 2.0 0.0 X 0 0 0 JODY HOROWITZ MARSH BOARD MEMBER (PT YR) 2.0 3.0 X 0 0 0 MALISSIA CLINTON BOARD MEMBER 2.0 0.0 X 0 0 0 MORGAN CHU BOARD MEMBER 2.0 3.0 X 0 0 0 NORMAN PAYSON MD BOARD MEMBER 2.0 2.0 X 0 0 0 PHILIP FASANO BOARD MEMBER 2.0 0.0 X 0 0 0 RANDOLPH BEATTY BOARD MEMBER 2.0 0.0 X 0 0 0 RONALD SARGENT BOARD MEMBER 2.0 0.0 X 0 0 0 SELWYN ISAKOW BOARD MEMBER/CHAIR 2.0 3.0 X X 0 0 0 STEVEN FINK BOARD MEMBER 2.0 3.0 X 0 0 0 SUZANNE VAUTRINOT BOARD MEMBER 2.0 0.0 X 0 0 0 WILLIAM POST BOARD MEMBER 2.0 0.0 X 0 0 0 GREGORY SCHETINA GENERAL COUNSEL/SECRETARY 15.0 45.0 X 251396 754186 187797 JEFFREY WALKER COO/ASSISTANT SECRETARY 15.0 45.0 X 197499 592495 58645 JENNIFER PARKHURST CFO/TREASURER 15.0 45.0 X 307559 922674 80629 KRISTIN BERTELL CHIEF PHIL OFF/ASST SECRETARY 51.0 9.0 X 1002004 176824 182598 ROBERT W STONE PRESIDENT/CEO 21.0 39.0 X 1015920 1886709 463619 DONALD MATTHEWSON ASSISTANT TREASURER - INCOMING 15.0 45.0 X 0 0 0 JONATHAN REUTER VP FACILITIES & CONSTRUCTION 6.0 54.0 X 44462 400164 43609 MARK HULSE CHIEF DIGITAL OFFICER 15.0 45.0 X 184267 552800 76038 ANNETTE WALKER PRESIDENT COH OC CANCER CTR 60.0 0.0 X 747838 0 45717 DAVID A HORNE VICE PROVOST 3.0 57.0 X 34875 662606 58532 DEBRA F FIELDS EVP CHIEF TRANSFORMATION OFF 15.0 45.0 X 291432 874294 203665 HARLAN LEVINE MD PRES STRATEGY & BUS VENTURES 3.0 57.0 X 94322 1792118 253702 STEVEN T ROSEN MD PROVOST, CANCER CTR DIRECTOR 9.0 51.0 X 280960 1592101 233383 WILLIAM SARGEANT FORMER OFFICER 0.0 0.0 X 138487 415461 48718 CORNELIS VAN DEN BERG FORMER OFFICER 15.0 45.0 X 195276 585827 32318 MICHAEL A FRIEDMAN MD FORMER OFFICER 48.0 12.0 X 153496 38374 38572 NATHAN C CHAPPELL FORMER OFFICER 60.0 0.0 X 521216 0 71553 5461009 11246633 2079095 77 true true false CHAPMAN CUBINE ADAMS HUSSEY 1600 wilson Blvd Suite 300 Arlington VA 22209 PROF. FUNDARISING 4979600 ACCENTURE LLP 800 Corporate Pointe Suite 100 Culver City CA 90230 Consulting Services 2004403 LATHAM WATKINS 355 S Grand Ave Suite 100 Los Angeles CA 90071 Legal Services 953228 9TH WONDER 8687 Melrose Ave G300-9W West Hollywood CA 90069 Marketing Services 796308 THREE SIXTY ADVISORY GROUP LLC 1810 W KENNEDY BLVD TAMPA FL 33606 consulting services 736397 25 3407022 22663026 87862908 3936938 113932956 0 24768117 24768117 0 379602654 379602654 917284 0 0 0 917284 0 917284 917284 1036634388 406591 965452983 465000 71181405 -58409 71122996 71122996 271763 3407022 155715 116048 116048 0 0 0 0 0 0 INVESTMENT INCOME FROM K-1'S 525990 1803553 0 1803553 0 MISCELLANEOUS INCOME 900099 125429 0 0 125429 CASH SURRENDER VALUE GAIN 900099 93028 0 0 93028 2022010 592482065 0 1803553 476745556 424657006 424657006 0 0 0 0 0 0 3213392 5897 2554945 652550 1116681 109122 807602 199957 25806005 924558 14604168 10277279 518956 18112 274336 226508 2318107 74969 1429839 813299 1744517 59660 1042335 642522 0 0 0 0 1092797 594752 498045 68841 0 68841 0 0 0 0 0 5430865 5430865 0 0 0 0 10143127 148946 4086738 5907443 694867 27 585187 109653 3169380 157116 2372707 639557 2297695 43366 1679261 575068 0 0 0 0 581388 18282 322758 240348 1198863 54747 616383 527733 0 0 0 0 488974 15400 287775 185799 0 0 0 0 0 0 0 0 1259652 41296 764399 453957 216907 0 216907 0 Legal Settlement 2000000 0 2000000 0 Dues and Subscriptions 140190 2508 104441 33241 Tax & Licensing 105913 2 105776 135 ALL OTHER EXPENSE 259625 2619 86295 170711 488523748 426333633 34605445 27584670 X 9309072 459822 4892438 3956812 17160398 25922088 86439859 11743516 70620682 72500197 17525803 61375283 0 0 0 0 106 0 0 0 39134 79479 27605280 12758535 14220091 14846745 579989648 770540237 749909179 763125003 46418958 51383958 0 0 28642586 24885614 1610966444 1796402120 8518420 9872429 0 0 822551 1491707 0 0 0 0 0 0 0 0 0 0 53848048 69599731 63189019 80963867 X 1006259715 1147588959 363855659 375269666 177662051 192579628 1547777425 1715438253 1610966444 1796402120 X 103958317 -62288330 0 0 0 125990841 X false true X true false X 125760188 130758956 124283559 141961318 113932956 636696977 0 0 125760188 130758956 124283559 141961318 113932956 636696977 29472782 607224195 304115165 345514456 407477362 467357611 407091608 1931556202 345140 275842 322852 56740 116048 1116622 494427 76320 7049 92367 218457 888620 2570258421 0.23625 0.25090 X FORM 990, SCHEDULE A, SECTION C, LINE 17A CITY OF HOPE HAS A CALCULATED PUBLIC SUPPORT PERCENTAGE FOR TAX YEAR 2018 OF 23.63 PERCENT, WHICH IS BELOW THE 33 1/3 PERCENTAGE SPECIFIED UNDER THE PUBLIC SUPPORT TEST. INCLUDED IN TOTAL SUPPORT IS REVENUE FROM ONE LICENSING ARRANGEMENT UNDER WHICH CITY OF HOPE LICENSED TO GENENTECH, INC. SUBSTANTIAL RIGHTS IN THREE PATENTS IN EXCHANGE FOR THE PAYMENT OF ROYALTIES FROM GENENTECH. THESE PATENTS ARE CO-OWNED WITH GENENTECH, AND EMERGED FROM RESEARCH DONE IN THE EARLY 1980S BY TWO CITY OF HOPE SCIENTISTS, WORKING IN COLLABORATION WITH GENENTECH SCIENTISTS, ON DEVELOPING NOVEL METHODS OF PRODUCING MONOCLONAL ANTIBODIES USING RECOMBINANT DNA TECHNOLOGY. THE ROYALTY REVENUE RECEIVED IN CONNECTION WITH THE PATENTS IS GENERATED FROM SALES OF DRUGS BY GENENTECH AS WELL AS FROM ROYALTIES AND OTHER AMOUNTS PAID BY ITS LICENSEES. THESE ROYALTY REVENUES REPRESENT APPROXIMATELY $1,824,000,000 OVER THE FIVE FISCAL YEARS PRESENTED IN PART II, SECTION B. THE INCLUSION OF THIS AMOUNT IN THE DENOMINATOR DRIVES DOWN THE PUBLIC SUPPORT PERCENTAGE. REMOVING ROYALTY REVENUES FROM THE DENOMINATOR PROVIDES A PUBLIC SUPPORT PERCENTAGE WELL ABOVE 33 1/3 PERCENT. THIS REVENUE STREAM HELPED SUPPORT CITY OF HOPE'S MISSION AND PROGRAMS. THE PATENTS EXPIRED IN THE FIRST QUARTER OF FISCAL YEAR 2019, AND CITY OF HOPE IS NOW RECEIVING CARRYOVER REVENUE RELATED TO SALES OF DRUGS MANUFACTURED BEFORE THE EXPIRY DATE. CITY OF HOPE HAS A CONTINUOUS AND WELL DEVELOPED PROGRAM FOR SOLICITATION OF CHARITABLE CONTRIBUTIONS. THIS PROGRAM INCLUDES A NATIONWIDE NETWORK OF MORE THAN TWO DOZEN INDUSTRY GROUPS, CONSISTING OF COMPANIES AND THEIR SUPPORTERS WITHIN A COMMON INDUSTRY; CHAPTER GROUPS, MADE UP OF INDIVIDUAL VOLUNTEERS IN CITIES ACROSS THE COUNTRY; AND OTHER PUBLIC CHARITIES THAT HOST FUNDRAISING EVENTS DIRECTLY BENEFITING CITY OF HOPE. BEYOND THESE GROUPS, AS WELL AS CORPORATE SPONSORS AND INDIVIDUAL BENEFACTORS, CITY OF HOPE ALSO HAS A WELL DIVERSIFIED FUNDRAISING NETWORK THROUGH EMPLOYEE GIVING PROGRAMS, DIRECT MAIL CAMPAIGNS, AND SPECIAL EVENTS THAT PROMOTE CITY OF HOPE'S MISSION. CITY OF HOPE RECEIVES CONTRIBUTIONS FROM A WIDE BASE OF SUPPORTERS AS EVIDENCED IN SCHEDULE B OF THIS 990. CITY OF HOPE MAINTAINS AN ENDOWMENT FUND THAT HAS GROWN OVER THE PAST FOUR YEARS, INCLUDING THROUGH FUNDRAISING. CITY OF HOPE IS GOVERNED BY A BOARD WITH KNOWLEDGE AND EXPERTISE IN AREAS IMPORTANT TO CITY OF HOPE'S MISSION AND OPERATIONS AND WHICH REPRESENTS THE BROADER INTERESTS OF THE GENERAL PUBLIC. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 322069491 32771725 394645 0 6177172 817607 348241082 296264548 4604142 27012931 5166877 645253 322069491 255620513 6624027 40159719 5436378 703333 296264548 235185766 8166414 24345193 11507592 569268 255620513 223428148 23274849 -7019754 3976176 521301 235185766 0.26930 0.55300 0.17770 false false 1847000 4130601 5977601 6808333 2223743 4584590 58558 58558 0 13657502 10476234 3181268 1103286 1103286 14846745 Alternative Investments 763125003 F 763125003 0 DUE TO AFFILIATES 49027879 ANNUITANT OBLIGATIONS 19067825 OTHER LIABILITIES 1504027 69599731 X SCHEDULE D, PART V, LINE 4 CITY OF HOPE HAS BOARD DESIGNATED ASSETS OR QUASI-ENDOWMENT FUNDS AND OTHER PERMANENT FUNDS THAT ARE AVAILABLE TO FUND RESEARCH, PATIENT CARE, HEALTH EDUCATION AND MEDICAL EQUIPMENT AND BUILDINGS, AS DETERMINED BY DONOR AGREEMENTS, MANAGEMENT AND THE BOARD OF DIRECTORS. SCHEDULE D, PART X, LINE 2 THE FOLLOWING PARAGRAPH IS FROM THE CONSOLIDATED CITY OF HOPE AUDITED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2019 (WHICH INCLUDES CITY OF HOPE, CITY OF HOPE AUXILIARIES (AUXILIARIES), CITY OF HOPE NATIONAL MEDICAL CENTER, THE CITY OF HOPE MEDICAL FOUNDATION, SOUTHERN CALIFORNIA RADIATION ONCOLOGY, LLC, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, ACCESS CITY OF HOPE, LCC, AND THE BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE): FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ACCOUNTING STANDARDS CODIFICATION TOPIC ASC 740, INCOME TAXES, CLARIFIES THE ACCOUNTING FOR INCOME TAXES BY PRESCRIBING A MINIMUM RECOGNITION THRESHOLD THAT A TAX POSITION IS REQUIRED TO MEET BEFORE BEING RECOGNIZED IN THE FINANCIAL STATEMENTS. ASC 740 ALSO PROVIDES GUIDANCE ON DE-RECOGNITION, MEASUREMENT, CLASSIFICATION, INTEREST AND PENALTIES, DISCLOSURE AND TRANSITION. THE GUIDANCE CONTAINED IN ASC 740 IS APPLICABLE TO PASS-THROUGH ENTITIES AND TAX-EXEMPT ORGANIZATIONS. CITY OF HOPE HAS NO SIGNIFICANT UNCERTAIN TAX POSITIONS OR TAX LIABILITY FOR TAX BENEFITS, INTEREST OR PENALTIES ACCRUED AT SEPTEMBER 30, 2019 AND 2018. Central America and the Caribbean Investments 157961289 Central America and the Caribbean Fundraising 0 East Asia and the Pacific Fundraising 0 Europe (Including Iceland and Greenland) Fundraising 0 North America Fundraising 0 South America Fundraising 0 Middle East and North Africa 2 Fundraising 8634 2 2 157969923 157969923 true false true true true false SCHEDULE F, PART I, LINE 3 INVESTMENT ACTIVITIES OF THE CITY OF HOPE INCLUDE INVESTMENTS IN MULTIPLE VEHICLES THAT PROVIDE INVESTMENT INCOME AND RETURNS TO FURTHER THE INSTITUTION'S MISSION AND PROGRAMS. AS A RESULT, SOME INVESTMENTS ARE HELD IN OFFSHORE HEDGE FUNDS, MAINLY REGISTERED AS CAYMAN EXEMPTED CORPORATIONS. THESE INVESTMENTS HELP MITIGATE RISK IN THE PORTFOLIO AND REPRESENT APPROXIMATELY 9.99% OF CITY OF HOPE'S OVERALL CASH AND INVESTMENT PORTFOLIO. CITY OF HOPE HAS HOLDINGS THAT INCLUDE EQUITY COMINGLED FUNDS THAT INVEST PRIMARILY IN MARKETABLE EQUITY SECURITIES. THESE FUNDS ARE SUBJECT TO CERTAIN NOTICE REQUIREMENTS, BUT CAN BE LIQUIDATED AT LEAST MONTHLY. ALTERNATIVE INVESTMENTS ALSO INCLUDE HEDGE FUNDS AND LIMITED PARTNERSHIP FUNDS INVESTED IN REAL ESTATE AND NATURAL RESOURCES, MASTER LIMITED PARTNERSHIPS, PRIVATE EQUITY AND PRIVATE REAL ASSETS. ALL OF THESE INVESTMENTS HAVE BEEN INCLUDED IN FORM 990, PART X, LINE 12. CITY OF HOPE DOES NOT HAVE ANY PHYSICAL PRESENCE OF EMPLOYEES OUTSIDE OF THE UNITED STATES. HOWEVER, ITS REPUTATION AS A WORLD CLASS RESEARCH AND TREATMENT FACILITY IS INTERNATIONALLY RECOGNIZED. AS A RESULT OF THIS RECOGNITION, CITY OF HOPE RECEIVES DONATIONS AND GRANTS FROM PERSONS AND CORPORATIONS OUTSIDE OF THE UNITED STATES. ADDITIONALLY, CITY OF HOPE EMPLOYEES TRAVELED OUTSIDE THE UNITED STATES TO DISCUSS DONATION OPPORTUNITIES WITH INTERNATIONAL PROSPECTS. X X X X X X true CHAPMAN CUBINE ET AL 100 MONTGOMERY ST SAN FRANCISCO CA 94104 EMAIL/MAIL SOLICITS false 13330514 4963653 8366861 DONOR SERVICES GROUP 6715 SUNSET BLVD LOS ANGELES CA 90028 PHONE SOLICITS false 14486 29032 -14546 MAL WARWICK ASSOCIATES 2550 NINTH STREET BERKELEY CA 94710 MAIL/PHONE Solicits false 0 144140 0 MARKET SMART LLC 5906 MAIDEN LANE BETHESDA MD 20817 WEBSITE CONTENT false 0 268079 0 TSM DONOR ENGAGEMENT TEAM 155 COMMERCE DRIVE FREEDOM PA 15042 Phone Solicits false 0 25960 0 13345000 5430864 8352315 All States LBFAC Gala 1164992 908210 256782 0 0 90453 0 10500 6000 WALK4HOPE LA 930740 930740 0 0 0 0 0 0 16 1575883 1562763 13120 0 0 30274 0 2500 15675 3671615 3401713 269902 0 0 120727 0 13000 21675 155402 114500 See Part IV. 1500 EAST DUARTE ROAD DUARTE CA 91010 SCHEDULE G, PART I, LINE 2B MARKET SMART LLC PROVIDED CITY OF HOPE WITH DESIGN OF INTERNET WEBSITES AND/OR COLLATERAL MATERIALS RELATED TO PLANNED GIVING AND ESTATE PLANNING OPPORTUNITIES. THERE IS NO MEANINGFUL WAY FOR CITY OF HOPE TO ATTRIBUTE GROSS RECEIPTS FROM DONOR SOURCES TO THESE ACTIVITIES DUE TO THE LONG-TIME HORIZON TYPICALLY ASSOCIATED WITH THESE GIFT GIVING VEHICLES. ADDITIONALLY, INTERNET AND OTHER NEW MEDIA TECHNOLOGIES ARE DIRECTED TOWARD LARGE, HETEROGENEOUS, AND ANONYMOUS AUDIENCES. THE ABILITY TO TRACK WHETHER DONATIONS WERE A RESULT OF THIS TYPE OF MARKETING OUTREACH WOULD BE UNKNOWN TO CITY OF HOPE UNLESS THE DONOR SELF-IDENTIFIED AS HAVING BEEN INFLUENCED BY THIS OUTREACH. CHAPMAN CUBINE ADAMS HUSSEY, LTD. (CCAH) IS A DIRECT RESPONSE FUNDRAISING CONSULTING FIRM WHICH PROVIDED CITY OF HOPE SERVICES DIRECTED TO RAISING FUNDS FROM THE PUBLIC THROUGH DIRECT MAIL, TELEMARKETING AND ONLINE COMMUNICATIONS. CITY OF HOPE ALSO PAID AN ADDITIONAL $2,153,074 TO CCAH TO COVER DIRECT MAILING AND POSTAGE EXPENSES. TOTAL PAYMENT FOR SUCH SERVICES IS REPORTED IN SCHEDULE G, PART I, LINE 2B, COLUMN (V). DONOR SERVICES GROUP, MAL WARWICK & ASSOCIATES AND TSM DONOR ENGAGEMENT TEAM ARE TELEMARKETING FUNDRAISING FIRMS WHICH PROVIDED CITY OF HOPE FUNDRAISING SERVICES FOR SOLICITING CONTRIBUTIONS FROM THE PUBLIC. true City of Hope National Medical Center 1500 E Duarte Road Duarte CA 91010 951683875 501(C)(3) 6089081 SEE PART IV Beckman Research Institute of the COH 1450 E Duarte Road Duarte CA 91010 953432210 501(C)(3) 349931002 SEE PART IV City of Hope Medical Foundation 1500 East Duarte Road Duarte CA 91010 274803222 501(C)(3) 42000000 SEE PART IV The Translational Genomics Research Inst 445 N 5th Street Phoenix AZ 85004 753065445 501(C)(3) 26636923 SEE PART IV 4 SCHEDULE I, PART I, LINE 2 CITY OF HOPE EXISTS TO FINANCIALLY SUPPORT ITS OPERATING SUBSIDIARY ORGANIZATIONS, THE CITY OF HOPE NATIONAL MEDICAL CENTER, THE CITY OF HOPE FOUNDATION, THE BECKMAN RESEARCH INSTITUTE AND THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE IN FURTHERING INNOVATIVE RESEARCH AND CANCER TREATMENT. CITY OF HOPE IS THE SOLE CORPORATE MEMBER OF THESE SUBSIDIARY ORGANIZATIONS AND MONITORS THEIR ACTIVITIES TO ENSURE THEY ARE FULFILLING THEIR PATIENT CARE AND RESEARCH MISSIONS AND TO ENSURE THEY ARE OPERATING IN ACCORDANCE WITH THE FUNDRAISING AND GRANT MAKING ACTIVITIES OF CITY OF HOPE. X true true X X X X X X false true false false false false false true false GREGORY SCHETINA GENERAL COUNSEL/SECRETARY 129638 388913 110767 332302 10991 32971 35347 106042 11602 34806 298345 895034 27923 83769 JEFFREY WALKER COO/ASSISTANT SECRETARY 122562 367687 63654 190961 11283 33847 8000 24000 6661 19984 212160 636479 0 0 JENNIFER PARKHURST CFO/TREASURER 174449 523345 102616 307846 30494 91483 13500 40500 6657 19972 327716 983146 0 0 KRISTIN BERTELL CHIEF PHIL OFF/ASST SECRETARY 451623 79698 420545 74214 129836 22912 121917 21515 33291 5875 1157212 204214 155704 27477 ROBERT W STONE PRESIDENT/CEO 466471 866303 512018 950891 37431 69515 149577 277787 12689 23566 1178186 2188062 112817 209517 WILLIAM SARGEANT FORMER OFFICER 97110 291329 0 0 41377 124132 5591 16773 6589 19765 150667 451999 0 0 JONATHAN REUTER VP FACILITIES & CONSTRUCTION 32920 296282 9246 83216 2296 20666 1070 9629 3291 29619 48823 439412 0 0 MARK HULSE CHIEF DIGITAL OFFICER 126125 378374 41192 123577 16950 50849 10625 31875 8385 25153 203277 609828 0 0 ANNETTE WALKER PRESIDENT COH OC CANCER CTR 411654 0 328462 0 7722 0 28333 0 17384 0 793555 0 0 0 DAVID A HORNE VICE PROVOST 23844 453027 8659 164514 2372 45065 1118 21246 1808 34360 37801 718212 0 0 DEBRA F FIELDS EVP CHIEF TRANSFORMATION OFF 149395 448186 131206 393616 10831 32492 40016 120048 10900 32701 342348 1027043 29531 88594 HARLAN LEVINE MD PRES STRATEGY & BUS VENTURES 44887 852850 44988 854774 4447 84494 10947 208000 1738 33017 107007 2033135 8753 166297 STEVEN T ROSEN MD PROVOST, CANCER CTR DIRECTOR 128580 728620 135748 769236 16632 94245 30459 172598 4549 25777 315968 1790476 27000 153000 CORNELIS VAN DEN BERG FORMER OFFICER 110500 331499 48496 145488 36280 108840 2108 6324 5972 17914 203356 610065 17211 51631 MICHAEL A FRIEDMAN MD FORMER OFFICER 149086 37271 0 0 4410 1103 11590 2897 19268 4817 184354 46088 0 0 NATHAN C CHAPPELL FORMER OFFICER 403001 0 115425 0 2790 0 33688 0 37865 0 592769 0 0 0 SCHEDULE J, PART I, LINE 1A THE ORGANIZATION PERMITS FIRST CLASS TRAVEL FOR CERTAIN OFFICERS, DIRECTORS, AND KEY EXECUTIVES IN LIMITED CIRCUMSTANCES WHEN SPECIFIED TRAVEL CRITERIA ARE MET. SCHEDULE J, PART I, LINE 4B CITY OF HOPE ALSO HAS A NON-QUALIFIED SECTION 457(F) EXECUTIVE SUPPLEMENTAL ACCUMULATION PLAN THAT IS DESIGNED AND MAINTAINED TO PROVIDE A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES WITH DEFERRED COMPENSATION. THE PLAN VESTS AFTER THREE (3) FISCAL YEARS OF SERVICE AND THE VESTED TOTALS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN B (III). PRIOR TO VESTING, THE ANNUAL AMOUNTS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN C. PURSUANT TO THE PLAN DOCUMENT, VESTED PARTICIPANTS ARE ENTITLED TO WITHDRAW FROM THEIR VESTED ACCOUNT AN AMOUNT EQUAL TO THE FEDERAL, STATE, LOCAL AND FICA TAXES THEY OWE. THESE AMOUNTS ARE REMITTED TO THE APPROPRIATE TAXING AUTHORITIES ON BEHALF OF THE PARTICIPANTS. DURING CALENDAR YEAR 2018 THE FOLLOWING INDIVIDUALS WITHDREW THE REFERENCED AMOUNTS TO COVER SUCH TAXES: KRISTIN BERTELL $ 50,101 CORNELIS VAN DEN BERG $ 46,611 STEVEN T. ROSEN MD $ 38,212 ROBERT W. STONE $ 30,601 DEBRA F. FIELDS $ 11,292 GREGORY SCHETINA $ 9,682 DAVID A. HORNE $ 8,415 MICHAEL A. FRIEDMAN MD $ 2,164 THESE AMOUNTS HAVE BEEN INCLUDED IN THE PARTICIPANTS INCOME ON SCHEDULE J, PART II COLUMN B(III). WILLIAM SARGEANT ENDED EMPLOYMENT WITH THE CITY OF HOPE NATIONAL MEDICAL CENTER DURING THE CALENDAR YEAR ENDING DECEMBER 31, 2018 AND RECEIVED DISTRIBUTIONS FROM THE PLAN TOTALING $243,977. THIS AMOUNT HAS BEEN REPORTED AS TAXABLE COMPENSATION IN EITHER THE CURRENT YEAR OR IN A PRIOR YEAR 990 IN SCHEDULE J, PART II, COLUMN B(III). SCHEDULE J, PART I, LINE 7 CITY OF HOPE EXECUTIVES AND SOME KEY EMPLOYEES ARE ELIGIBLE TO RECEIVE INCENTIVE COMPENSATION UNDER AN ANNUAL INCENTIVE PLAN (AIP) TIED TO THREE (3) KEY INDICATORS AND TWO OR MORE INDIVIDUAL OBJECTIVES. THE KEY INDICATORS REFLECT KEY AREAS OF STRATEGIC FOCUS AND THE EXEMPT HEALTHCARE MISSION OF THE CITY OF HOPE AND AFFILIATES AND ARE BOTH FINANCIAL AND NON-FINANCIAL. THE POTENTIAL INCENTIVE COMPENSATION IS BASED ON A WEIGHTED AVERAGE AMONG ALL INDICATORS AND IS PAID AS A PERCENTAGE OF EACH INDIVIDUAL PARTICIPANT'S BASE COMPENSATION. THE KEY INDICATORS ARE WEIGHTED AT 50% AND THE INDIVIDUAL OBJECTIVES ARE WEIGHTED AT 50%. THE AIP IS UNDER THE CONTROL OF AND ADMINISTERED BY THE INDEPENDENT DIRECTORS SERVING ON THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE. TO BE ELIGIBLE, THE PARTICIPANTS IN THE AIP MUST BE EMPLOYED BY THE CITY OF HOPE AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. CITY OF HOPE MAY IN ITS DISCRETION CANCEL ALL OR A PORTION OF ANY INCENTIVE PLAN PAYMENT OR AWARD TO ANY PARTICIPANT, WHETHER BEFORE OR FOLLOWING PAYMENT OF SUCH AWARD, SUBJECT TO COMPLIANCE WITH APPLICABLE LAW, UNDER THESE CIRCUMSTANCES (CANCELLATION POLICY): A) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY RESTATES OR OTHERWISE ADJUSTS THE ANNUAL PERFORMANCE MEASUREMENT CALCULATION IN A MANNER THAT WOULD REDUCE THE SIZE OF THE AWARD OR PAYMENT, OR; B) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY DETERMINES THAT ONE OR MORE OF THE ANNUAL PERFORMANCE MEASUREMENT CALCULATIONS ON WHICH THE AWARD IS BASED OR IS PAID ARE MATERIALLY INACCURATE. DURING CALENDAR YEAR 2018 CITY OF HOPE PAID THE INCENTIVE COMPENSATION EARNED FOR FISCAL YEAR 2018 AND THESE AMOUNTS HAVE BEEN REPORTED IN SCHEDULE J, PART II, COLUMN B(II). CITY OF HOPE ALSO HAS AN EXECUTIVE LONG TERM INCENTIVE PLAN (LTI) FOR CERTAIN EXECUTIVES THAT IS DESIGNED TO DRIVE LONG-TERM ORGANIZATIONAL PERFORMANCE AND TRANSFORMATION BY ALIGNING EXECUTIVES WITH THE MULTI-YEAR STRATEGIC PLAN AND INCENTIVIZING THEM FOR ACHIEVING KEY ORGANIZATIONAL AND STRATEGIC OBJECTIVES AND GOALS. WITH THREE-YEAR VESTING PERIODS, THE LTI ALSO PROVIDES A MEANS FOR RETAINING KEY EXECUTIVE TALENT. THE PERFORMANCE PERIOD OF THE PLAN (CYCLE 4) RUNS FROM OCTOBER 1, 2015 THROUGH SEPTEMBER 30, 2018, WITH A NEW THREE YEAR PERFORMANCE PERIOD BEGINNING EACH OCTOBER 1 THEREAFTER (E.G., CYCLE 5 RUNS FROM OCTOBER 1, 2016 THROUGH SEPTEMBER 30, 2019). TO BE ELIGIBLE TO PARTICIPATE IN ANY PAYOUT UNDER THE LTI, PARTICIPANTS MUST BE ACTIVELY EMPLOYED BY CITY OF HOPE AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. WHILE THE LTI DOES MEET THE REQUIREMENTS FOR A SUBSTANTIAL RISK OF FORFEITURE, AS OF THE CALENDAR YEAR ENDING DECEMBER 31, 2018, THE POTENTIAL LTI AMOUNTS HAVE BEEN ESTIMATED AND ACCRUED DURING THE CURRENT TAX YEAR AND ARE REPORTED AS DEFERRED COMPENSATION TO THE PLAN PARTICIPANTS IN SCHEDULE J, PART II, COLUMN C. THE LTI IS SUBJECT TO THE SAME CANCELLATION POLICY AS THE AIP DESCRIBED ABOVE. PARTICIPANTS WHO MET THE ELIGIBILITY CRITERIA RECEIVED PAYOUT OF PLAN CYCLE 4 LTI INCENTIVES (OCTOBER 1, 2015 THROUGH SEPTEMBER 30, 2018) IN DECEMBER 2018. THESE AMOUNTS HAVE BEEN REFLECTED IN SCHEDULE J PART II, COLUMN B(II). X 113 3471938 Market Value X 1 465000 Market Value 0 false true true SCHEDULE M, PART I, COLUMN B LINE 9-SECURITIES AND LINE 17-REAL ESTATE-RESIDENTIAL ARE ALL REPORTED AS ITEMS CONTRIBUTED. SCHEDULE M, PART I, LINE 32B CITY OF HOPE USES THIRD PARTY REAL ESTATE BROKERS AND AGENTS TO ASSIST IN THE SALE OF DONATED REAL ESTATE. THIRD PARTY ACTIVITIES ARE MONITORED CLOSELY THROUGH CITY OF HOPE CORPORATE REAL ESTATE STAFF. SELECTION OF THIRD PARTIES IS DONE THROUGH INTERVIEWS OF SEVERAL QUALIFIED INDIVIDUALS OR FIRMS AND SELECTIONS ARE BASED ON QUALIFICATIONS SUCH AS SKILL, KNOWLEDGE, EXPERIENCE, EDUCATION, LICENSURE, CERTIFICATIONS, ETC. BACKGROUND AND REFERENCE CHECKS ARE CONDUCTED ON THE SELECTED THIRD PARTY. ADDITIONALLY, SELECTION IS BASED ON COST AND WE REQUEST THIRD PARTIES TO DISCOUNT STANDARD COMMISSIONS, FEES AND COSTS ASSOCIATED WITH THE SERVICES THEY PROVIDE. FORM 990, PART I, LINE 6 THE PHILANTHROPIC SPIRIT OF THOUSANDS OF VOLUNTEERS NATIONWIDE MAKES IT POSSIBLE FOR CITY OF HOPE AND AFFILIATES TO CONTINUE ITS LIFE-SAVING WORK. THIS SUPPORT PROVIDES A MAJOR PORTION OF OUR RESEARCH AND TREATMENT BUDGET EACH YEAR AND HELPS US HELP THOSE IN NEED THROUGHOUT THE YEAR. IN THE CURRENT YEAR, A SUBSTANTIAL NUMBER OF UNPAID VOLUNTEERS HAVE MADE SIGNIFICANT CONTRIBUTIONS OF THEIR TIME TO DEVELOP CITY OF HOPE'S FUNDRAISING NETWORK, PRINCIPALLY THROUGH DEVELOPMENT AND EDUCATIONAL PROGRAMS. THE VALUE OF THIS CONTRIBUTED TIME IS NOT REFLECTED IN THE TAX RETURNS OR THE AUDITED FINANCIAL STATEMENTS SINCE IT IS NOT SUSCEPTIBLE TO OBJECTIVE MEASUREMENT OR VALUATION. FORM 990, PART III, LINE 1 - CONTINUATION CITY OF HOPE, AN INNOVATIVE BIOMEDICAL RESEARCH, TREATMENT AND EDUCATIONAL INSTITUTION, ACCOMPLISHES THIS DIRECTLY OR INDIRECTLY THROUGH ONE OR MORE SUBSIDIARIES OR AFFILIATES THAT WERE FORMED TO RAISE FUNDS IN SUPPORT OF OUTSTANDING PATIENT CARE, TO CONDUCT INNOVATIVE RESEARCH AND THE OFFERING OF VITAL EDUCATION PROGRAMS FOCUSED ON RAISING AWARENESS AND ELIMINATING DISEASES. CITY OF HOPE COLLECTIVELY REFERS TO CITY OF HOPE, CITY OF HOPE AUXILIARY NETWORK, CITY OF HOPE NATIONAL MEDICAL CENTER, CITY OF HOPE MEDICAL FOUNDATION, BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE, ACCESS CITY OF HOPE, LLC, SOUTHERN CALIFORNIA RADIATION ONCOLOGY LLC, AND THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE. FOUNDED IN 1913, CITY OF HOPE HAS BEEN DESIGNATED BY THE NATIONAL CANCER INSTITUTE AS A COMPREHENSIVE CANCER CENTER. OUR ROLE AS LEADERS IN PATIENT CARE, BASIC AND CLINICAL RESEARCH, AND THE TRANSLATION OF SCIENCE INTO TANGIBLE BENEFIT IS WIDELY ACKNOWLEDGED. OUR COMMUNITY INCLUDES RESEARCH ASSOCIATES, SCIENTISTS, DOCTORS, NURSES, ALLIED HEALTH PROFESSIONALS, GRADUATE STUDENTS, FUNDRAISING SPECIALISTS, MARKETING PROFESSIONALS, VOLUNTEERS AND EXTENSIVE OTHER SUPPORT STAFF. WE ARE UNITED BY OUR DESIRE TO FIND CURES, SAVE LIVES AND TRANSFORM THE FUTURE OF HEALTH. EVERY DISCOVERY WE MAKE AND EVERY NEW TREATMENT WE CREATE GIVES PEOPLE THE CHANCE TO LIVE LONGER, BETTER AND MORE FULLY. CITY OF HOPE CONTINUES TO BE A PIONEER OF PATIENT-CENTERED CARE AND REMAINS COMMITTED TO ITS TRADITION OF EXCEPTIONAL CARE FOR PATIENTS, FAMILIES AND COMMUNITIES AND IS SUPPORTED BY A NATIONAL FOUNDATION OF PHILANTHROPY. FORM 990, PART V, LINE 1B CITY OF HOPE ISSUES FORMS W-2G IN ACCORDANCE WITH REQUIREMENTS SET FORTH IN INTERNAL REVENUE SERVICE REGULATIONS. THE FORMS W-2G THAT ARE ISSUED BY CITY OF HOPE INCLUDE THOSE ISSUED TO PERSONS WHO WERE AWARDED PRIZES THROUGH RAFFLE OR OTHER DRAWING ACTIVITIES THAT TOOK PLACE THROUGH THE AUXILIARY NETWORK, FOR WHICH A SEPARATE 990 IS FILED UNDER THE NAME "CITY OF HOPE GROUP RETURN" FEIN - 02-0765554. FORM 990, PART V, LINE 2A MOST OF CITY OF HOPE'S OFFICERS AND KEY EMPLOYEES, AS WELL AS A FEW OF ITS HIGHEST COMPENSATED EMPLOYEES, PROVIDE SERVICES TO MORE THAN ONE CITY OF HOPE ENTITY, AND MANY OF THEM PROVIDE SERVICES TO ALL OF THE ENTITIES. FOR A NUMBER OF THESE CONCURRENTLY-EMPLOYED INDIVIDUALS, THE ENTITIES HAVE DESIGNATED THE MEDICAL CENTER AS THE "COMMON PAYMASTER", AS DEFINED IN SECTION 3121(S) OF THE INTERNAL REVENUE CODE. CITY OF HOPE REPORTS THESE CONCURRENT EMPLOYEES' TIME, EFFORT AND COMPENSATION ON THE INFORMATION RETURNS OF THE CITY OF HOPE ENTITIES BASED ON THE ESTIMATES OF THEIR TIME SPENT IN AND FOR EACH ENTITY. AS "COMMON PAYMASTER" THE MEDICAL CENTER ISSUES EACH OF THESE EMPLOYEES A SINGLE, COMBINED PAYCHECK AND ONE FORM W-2. FORM 990, PART VI, SECTION A, LINE 2 SUZANNE VAUTRINOT AND RONALD SARGENT HAVE A BUSINESS RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FORM 990 IS REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD OF DIRECTORS OF CITY OF HOPE, WHICH ASSISTS THE BOARD IN FULFILLING ITS RESPONSIBILITIES REGARDING FINANCIAL, ACCOUNTING, AND CORPORATE COMPLIANCE MATTERS OF THE AUXILIARY NETWORK. ADDITIONALLY, THE PREPARATION OF THE FORM 990 IS DONE BY AN EXTERNAL ACCOUNTING FIRM AND IS REVIEWED THOROUGHLY WITH INTERNAL LEADERSHIP AND EXTERNAL PARTICIPANTS, INCLUDING EY, AND RETAINED OUTSIDE TAX COUNSEL. PRIOR TO FILING, THE CITY OF HOPE FORM 990 IS MADE AVAILABLE TO VOTING MEMBERS OF THE CITY OF HOPE BOARD OF DIRECTORS FOR REVIEW. CITY OF HOPE (95-3435919) IS THE SOLE CORPORATE MEMBER OF THE CITY OF HOPE NATIONAL MEDICAL CENTER, THE CITY OF HOPE MEDICAL FOUNDATION, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, SOUTHERN CALIFORNIA RADIOLOGY ONCOLOGY LLC, ACCESS CITY OF HOPE AND BECKMAN RESEARCH INSTITUTE. FORM 990, PART VI, SECTION B, LINE 12C ALL EMPLOYEES OF CITY OF HOPE AND AFFILIATES, ITS BOARD OF DIRECTORS, BOARD COMMITTEE MEMBERS AND RESEARCH TEAM MEMBERS ARE COVERED BY CITY OF HOPE'S APPLICABLE CONFLICT OF INTEREST POLICIES. DETERMINATIONS AS TO WHETHER A CONFLICT OF INTEREST EXISTS AND REVIEW OF CONFLICT DISCLOSURES ARE MADE BY THE GENERAL COUNSEL, CHIEF COMPLIANCE OFFICER AND, AS APPLICABLE, THE CHAIR OF THE BOARD OR THE CONFLICT OF INTEREST AND COMMITMENT COMMITTEE, BASED UPON THE CLASSIFICATION OF PERSON MAKING THE DISCLOSURE. RESTRICTIONS IMPOSED ON PERSONS WITH AN ACTUAL OR PERCEIVED CONFLICT VARY, BASED UPON THE FACTS AND MAY INCLUDE: PROHIBITION FROM PARTICIPATING IN A GOVERNING BODY'S DELIBERATIONS AND VOTING ON A GIVEN TRANSACTION OR SET OF TRANSACTIONS; RECUSAL FROM THE DECISION-MAKING PROCESS RELATING TO BUSINESS TRANSACTIONS (E.G., PURCHASING DECISIONS); PROHIBITION FROM PARTICIPATING AS A PRINCIPAL INVESTIGATOR IN RESEARCH; AND DISCLOSURE OF FINANCIAL INTEREST IN RESEARCH STUDY INFORMED CONSENT FORMS AND PUBLICATIONS. MONITORING TRANSACTIONS FOR CONFLICTS OF INTEREST IS DONE THROUGH REQUIRED DISCLOSURES AND UPDATES BY PERSONS COVERED BY THE ORGANIZATION'S CONFLICT OF INTEREST POLICIES AND A CONCURRENT REVIEW OF SUCH DISCLOSURES AGAINST TRANSACTIONS. CITY OF HOPE'S POLICY PROVIDES FOR DISCIPLINARY ACTION AGAINST PERSONS COVERED BY THE CONFLICT OF INTEREST POLICIES WHO DO NOT COMPLY WITH POLICY REQUIREMENTS. FORM 990, PART VI, SECTION B, LINES 15A AND 15B THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE OF CITY OF HOPE'S BOARD OF DIRECTORS (COMMITTEE), PURSUANT TO A DELEGATION OF AUTHORITY FROM CITY OF HOPE'S BOARD OF DIRECTORS, IS RESPONSIBLE FOR SETTING THE COMPENSATION OF THE PRESIDENT AND CEO AND CERTAIN OTHER SENIOR EXECUTIVES. THE DIRECTORS ON THIS COMMITTEE ARE INDEPENDENT AND ADHERE TO A STRICT CONFLICT OF INTEREST POLICY AND DELIBERATION AND DECISION MAKING ARE SUBSTANTIATED IN THE MINUTES OF THE COMMITTEE'S MEETINGS. THE MINUTES ARE REVIEWED AND APPROVED AT THE NEXT MEETING OF THE COMMITTEE. AS PART OF THE DELIBERATION PROCESS, THE COMMITTEE RECEIVES ADVICE FROM AN INDEPENDENT, THIRD-PARTY COMPENSATION CONSULTANT WITH RESPECT TO EXECUTIVE COMPENSATION, REVIEWS COMPARABLE AND BENCHMARK DATA PRESENTED BY THE CONSULTANT, AND REVIEWS CURRENT COMPENSATION PHILOSOPHY, STRUCTURE, AND ADMINISTRATION OF THE EXECUTIVE CASH COMPENSATION PROGRAMS AT CITY OF HOPE AND AFFILIATES. THE COMMITTEE CARRIES OUT THE BOARD OF DIRECTORS' OVERALL RESPONSIBILITIES RELATING TO EXECUTIVE COMPENSATION. THE EXECUTIVE COMPENSATION PHILOSOPHY IS DESIGNED TO ASSIST IN ATTRACTING AND RETAINING THE CALIBER OF EXECUTIVE LEADERSHIP REQUIRED TO ENABLE CITY OF HOPE TO ACHIEVE THE HIGHEST LEVELS OF COMMUNITY BENEFIT, IMPACT TO CLINICAL CARE, QUALITY RESEARCH AND EFFICIENT PHILANTHROPIC DEVELOPMENT. THE COMMITTEE TARGETS THE 50TH PERCENTILE OF BASE SALARY AND THE 75TH PERCENTILE OF TOTAL CASH COMPENSATION OF THE MARKET IN WHICH CITY OF HOPE COMPETES FOR EXECUTIVES. UNDER THE AIP AND THE LTI DESCRIBED ABOVE, A SUBSTANTIAL PORTION OF EXECUTIVE COMPENSATION IS LINKED DIRECTLY TO PERFORMANCE GOALS APPROVED IN ADVANCE BY THE COMMITTEE. AS A RESULT, PERFORMANCE COMPENSATION MAY VARY FROM YEAR TO YEAR. GOAL SETTING UNDER THE AIP IS TIED TO ANNUAL PERFORMANCE, INCLUDING THE ATTAINMENT OF SPECIFIC BUSINESS OBJECTIVES FOR STRATEGIC AND FINANCIAL PERFORMANCE AS WELL AS NON-FINANCIAL MEASURES SUCH AS PATIENT SATISFACTION AND QUALITY OF PATIENT CARE. THE LTI IS DESIGNED TO DRIVE LONG-TERM ORGANIZATIONAL PERFORMANCE AND TRANSFORMATION BY ALIGNING EXECUTIVES WITH THE MULTI-YEAR STRATEGIC PLAN AND INCENTIVIZING THEM TO ACHIEVE KEY ORGANIZATIONAL AND STRATEGIC OBJECTIVES AND GOALS. WITH THREE-YEAR VESTING PERIODS, THE LTI ALSO PROVIDES A MEANS FOR RETAINING KEY EXECUTIVE TALENT. THE COMMITTEE CONDUCTS ANNUAL COMPENSATION REVIEWS FOR EXECUTIVES AND CERTAIN KEY EMPLOYEES AND THIS WAS LAST COMPLETED ON DECEMBER 14, 2019. THE COMPENSATION PROGRAMS AND RANGES FOR ALL OFFICERS AND KEY EMPLOYEES LISTED ON FORM 990, PART VII, AT THE SVP OR EQUIVALENT LEVEL AND ABOVE ARE REVIEWED BY THIS COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 CITY OF HOPE'S ARTICLES OF INCORPORATION ARE AVAILABLE TO THE PUBLIC FROM THE SECRETARY OF STATE. CITY OF HOPE AND AFFILIATES' AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON CITY OF HOPE'S WEBSITE, AND ITS CONFLICT OF INTEREST POLICIES ARE AVAILABLE BY WRITTEN REQUEST MADE TO THE CONFLICT OF INTEREST MANAGER. CITY OF HOPE'S BYLAWS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART XI, LINE 9 OTHER CHANGES IN NET ASSETS ADJUSTMENT RELATED TO CHANGES IN ACCOUNTING GUIDELINES - $125,990,841 ACCESS CITY OF HOPE LLC 1500 EAST DUARTE ROAD DUARTE CA 91010 842818450 ONCOLOGY SPPT DE 0 0 CITY OF HOPE CITY OF HOPE NATIONAL MEDICAL CENTER 1500 EAST DUARTE ROAD DUARTE CA 91010 951683875 HOSPITAL CA 501(C)(3) 3 City of Hope true BECKMAN RESEARCH INSTITUTE 1450 EAST DUARTE ROAD DUARTE CA 91010 953432210 RESEARCH CA 501(C)(3) 4 City of Hope true CITY OF HOPE MEDICAL FOUNDATION 1500 EAST Duarte Road Duarte CA 91010 274803222 Healthcare CA 501(C)(3) 3 City of Hope true THE TRANSLATIONAL GENOMIC RESEARCH INST 445 N 5TH STREET SUITE 600 PHOENIX AZ 85004 753065445 RESEARCH AZ 501(C)(3) 7 CITY OF HOPE true TGEN RESEARCH INSTITUTE FOUNDATION 445 N 5TH STREET SUITE 600 PHOENIX AZ 85004 331092191 FUNDRAISING AZ 501(C)(3) 7 TGEN true SOUTHERN CA RADIATION ONCOLOGY PO BOX 819067 DALLAS TX 75381 MGMT SERVICES CA NA N/A CHARITABLE REMAINDER TRUSTS (22) 1500 EAST DUARTE ROAD DUARTE CA 91010 SUPPORT CA COH Trust false false true true true false false false false false true false true true false true true true false false CITY OF HOPE NATIONAL MEDICAL CENTER B 6089081 FMV BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE B 349931002 FMV CITY OF HOPE MEDICAL FOUNDATION B 42000000 FMV THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE B 26636923 FMV BOARD OF GOVERNORS #71331 C 69004 FMV CALIFORNIA INSURANCE COUNCIL #71215 C 818590 FMV CONSTRUCTION & REAL ESTATE IND #71225 C 566181 FMV CONSTRUCTION INDUSTRIES ALLI #71082 C 846366 FMV DESERT COMMUNITIES WOMENS CNCL #71601 C 69935 FMV EAST ENDJEANNE KAYE LEAGUE #70732 C 92183 FMV FASHION AND RETAIL GROUP #70031 C 100253 FMV FOOD INDUSTRIES CIRCLE #71081 C 4266027 FMV HARDWARE HOME IMPROVEMENT IND #71183 C 4106331 FMV HOME FURNISHINGS & CONSUMER EL #70715 C 1557062 FMV LA COUNTY SHERIFF'S CHAPTER #71454 C 133806 FMV LA REAL ESTATECONSTRUCTION #71487 C 1115939 FMV MUSIC & ENTERTAINMENT INDUSTRY #71050 C 3266707 FMV NATIONAL LIFE INSURANCE CNCL #71651 C 200132 FMV NATIONAL OFFICE PRODUCTS CNCL #71362 C 2913592 FMV NATIONAL PROFESSIONAL SALON #70835 C 348176 FMV NO CA FOOD & DRUG INDS CIRCLE #71203 C 984098 FMV NO CA REAL ESTCONST BUS ALLI #71439 C 471492 FMV PACIFIC NORTHWEST FOOD IND CIR #71481 C 222416 FMV SOUTHWEST FOOD INDUSTRIES CIR #71562 C 148716 FMV CITY OF HOPE MEDICAL FOUNDATION J 450000 FMV CITY OF HOPE NATIONAL MEDICAL CENTER L 104479 FMV CITY OF HOPE NATIONAL MEDICAL CENTER M 10887759 FMV CITY OF HOPE NATIONAL MEDICAL CENTER O 8079054 FMV BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE O 61964 FMV CITY OF HOPE NATIONAL MEDICAL CENTER P 5001769 FMV BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE P 99218 FMV CITY OF HOPE NATIONAL MEDICAL CENTER Q 4749903 FMV CITY OF HOPE MEDICAL FOUNDATION Q 234050 FMV THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE D 25000000 FMV SCHEDULE R, PART II IN ACCORDANCE WITH THE FORM 990, SCHEDULE R INSTRUCTIONS, THE AUXILIARY CHAPTER ORGANIZATIONS INCLUDED IN THE CITY OF HOPE GROUP RETURN EXEMPTION ARE NOT REPORTED ON PART II OF SCHEDULE R AS RELATED TAX-EXEMPT ORGANIZATIONS. HOWEVER, THE TRANSACTIONS BETWEEN CITY OF HOPE AND THE AUXILIARY CHAPTER ORGANIZATIONS ARE REPORTED IN PART V OF SCHEDULE R, ON LINE 1 AND LINE 2, TO THE EXTENT THE TRANSACTIONS EXCEED THE $50,000 REPORTING THRESHOLD. THE TRANSACTIONS ARE REPORTED AT THEIR CASH VALUE.